Literature DB >> 7221482

Biopsy and prognosis for cutaneous malignant melanomas in clinical stage I.

K T Drzewiecki, C Ladefoged, H E Christensen.   

Abstract

The material comprises 225 patients. In 79 patients 35.1%) the tumour was closely excised and in a few cases biopsied before the patients underwent radical surgery. 146 patients were radically operated primarily. These two groups of patients are comparable with regard to sex, distribution of tumours on anatomical sites and the distribution of tumours with a given histological classification. We have ascertained that neither excision biopsy nor non-radical operation influences the prognosis if followed by radical operation within about 3 weeks.

Entities:  

Mesh:

Year:  1980        PMID: 7221482     DOI: 10.3109/02844318009106699

Source DB:  PubMed          Journal:  Scand J Plast Reconstr Surg        ISSN: 0036-5556


  5 in total

1.  Empirical Bayes estimation for additive hazards regression models.

Authors:  Debajyoti Sinha; M Brent McHenry; Stuart R Lipsitz; Malay Ghosh
Journal:  Biometrika       Date:  2009-06-26       Impact factor: 2.445

2.  Focused Information Criterion for Restricted Mean Survival Times: Non-Parametric or Parametric Estimators.

Authors:  Szilárd Nemes; Andreas Gustavsson; Alexandra Jauhiainen
Journal:  Entropy (Basel)       Date:  2022-05-16       Impact factor: 2.738

3.  Biopsy procedures, primary wide excisional surgery and long term prognosis in primary clinical stage I invasive cutaneous malignant melanoma.

Authors:  R W Griffiths; J C Briggs
Journal:  Ann R Coll Surg Engl       Date:  1985-03       Impact factor: 1.891

4.  Therapeutic and clinico-pathological factors in the survival of 1,469 patients with primary cutaneous malignant melanoma in clinical stage I. A multivariate regression analysis.

Authors:  K Søndergaard; G Schou
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985

5.  Surgery of primary melanomas.

Authors:  Piotr Rutkowski; Marcin Zdzienicki; Zbigniew I Nowecki; Alexander C J Van Akkooi
Journal:  Cancers (Basel)       Date:  2010-05-11       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.